1. Effects of supplementation with selenium, as selenized yeast, in a healthy male population from New Zealand
- Author
-
Jie Fu Yu, Yi-Ju Ko, Lynnette R. Ferguson, Shuotun Zhu, Nishi Karunasinghe, Christopher M. Triggs, Dug Yeo Han, and He Duan
- Subjects
Adult ,Male ,Cancer Research ,medicine.medical_specialty ,DNA damage ,Thioredoxin reductase ,Population ,Medicine (miscellaneous) ,chemistry.chemical_element ,Biology ,Selenium ,Internal medicine ,Yeasts ,medicine ,Male population ,Humans ,education ,Telomerase ,Aged ,chemistry.chemical_classification ,Aged, 80 and over ,education.field_of_study ,Glutathione Peroxidase ,Nutrition and Dietetics ,Glutathione peroxidase ,DNA ,Middle Aged ,Peroxides ,Red blood cell ,medicine.anatomical_structure ,Enzyme ,Endocrinology ,Oncology ,chemistry ,Immunology ,Dietary Supplements ,DNA Damage ,New Zealand - Abstract
Selenium (Se) supplementation was tested in a group of healthy men from Auckland, New Zealnd with selenized yeast (Selplex, 200 μg/day) as the supplementation mode. A set of biomarkers, including DNA damage levels and seleno-antioxidant enzyme levels, were evaluated at pre- and postsupplementation time points. Supplementation produced significant increases in serum Se levels, red blood cell (RBC) thioredoxin reductase (TR) activity and peroxide-induced DNA damage, when the mean baseline serum Se level was 110 ng/ml. Those with higher baseline serum Se levels gained less serum Se and showed a significant reduction of RBC glutathione peroxidase (GPx) activity by supplementation. The optimum benefits of supplementation on DNA stability are observed when the serum Se level reaches between >120 and
- Published
- 2013